Association of cumulative oxygen and carbon dioxide levels with neurologic outcome after pediatric cardiac arrest resuscitation: A multicenter cohort study
Marijn Albrecht , Rogier C.J. de Jonge , Jimena Del Castillo , Andrea Christoff , Matthijs De Hoog , Sangmo Je , Vinay M. Nadkarni , Dana E. Niles , Oliver Tegg , Kari Wellnitz , Corinne M.P. Buysse , pediRES-Q Collaborative Investigators
{"title":"Association of cumulative oxygen and carbon dioxide levels with neurologic outcome after pediatric cardiac arrest resuscitation: A multicenter cohort study","authors":"Marijn Albrecht , Rogier C.J. de Jonge , Jimena Del Castillo , Andrea Christoff , Matthijs De Hoog , Sangmo Je , Vinay M. Nadkarni , Dana E. Niles , Oliver Tegg , Kari Wellnitz , Corinne M.P. Buysse , pediRES-Q Collaborative Investigators","doi":"10.1016/j.resplu.2024.100804","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>We aimed to (1) determine the association between cumulative PaO<sub>2</sub> and PaCO<sub>2</sub> exposure 24 h post-return of circulation and survival with favorable neurologic outcome. And (2) to assess adherence to American Heart Association post-cardiac arrest care treatment goals (PaO<sub>2</sub> 75–100 mmHg and PaCO<sub>2</sub> 35–45 mmHg).</div></div><div><h3>Design and setting</h3><div>Prospectively collected data were analysed from five Pediatric Resuscitation Quality collaborative sites supplemented with retrospective PaO<sub>2</sub> and PaCO<sub>2</sub> data.</div></div><div><h3>Patients</h3><div>Children aged 1 day–17 years with return of circulation after cardiac arrest, admitted 2019–2022, with ≥ 4 arterial blood gasses spanning at least 12 h within 24 h post-return of ciculation, were eligible. Congenital cyanotic heart disease events were excluded.</div></div><div><h3>Measurements</h3><div>Area under the curve calculation provided hourly cumulative PaO<sub>2</sub> and PaCO<sub>2</sub> exposures per child and similarly guideline recommended cumulative ranges. The primary outcome was survival to hospital discharge with favorable neurologic outcome defined as a Pediatric Cerebral Performance Category 1–3, or no pre-arrest baseline difference.</div></div><div><h3>Main results</h3><div>Among 292 included children (median age 2.6 years (IQR 0.4–10.9)), 57 % survived to discharge and 48 % had favorable neurologic outcome (88 % of survivors). Cumulative PaO<sub>2</sub> and PaCO<sub>2</sub> exposure 0–24 h post-return of circulation were not significantly associated with favorable neurologic outcome in multivariable analysis (OR 1.0, 95 %CI 0.98–1.02 and OR 0.97, 95 %CI 0.87–1.09 respectively). Cumulative PaO<sub>2</sub> and PaCO<sub>2</sub> remained within guideline recommended ranges for 24 % and 58 % of children respectively with median areas under the curve over 0 – 24 h of 2664 mmHg (2151 – 3249 mmHg) for PaO<sub>2</sub> and 948 mmHg (853 – 1051 mmHg) for PaCO<sub>2</sub>. AHA post-cardiac arrest care guideline recommendations for PaO<sub>2</sub> (1800–2400 mmHg) and PaCO<sub>2</sub> (840–1080 mmHg) were recalculated as area under the curve ranges. Achieving both normoxia and normocapnia was observed in 12 % of children.</div></div><div><h3>Conclusions</h3><div>Cumulative PaO<sub>2</sub> and PaCO<sub>2</sub> exposure in the first 24 h post-return of circulation was not associated with survival with favorable neurologic outcome. Pediatric AHA post-cardiac arrest care guideline normoxia and normocapnia goals were often not met. Larger cohort studies are necessary to improve the accuracy of cumulative exposure calculations, assess the long-term effects of PaO<sub>2</sub> and PaCO<sub>2</sub> exposure, and explore the influence of other post-cardiac arrest care therapeutic strategies.</div></div>","PeriodicalId":94192,"journal":{"name":"Resuscitation plus","volume":"20 ","pages":"Article 100804"},"PeriodicalIF":2.1000,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Resuscitation plus","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666520424002558","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
We aimed to (1) determine the association between cumulative PaO2 and PaCO2 exposure 24 h post-return of circulation and survival with favorable neurologic outcome. And (2) to assess adherence to American Heart Association post-cardiac arrest care treatment goals (PaO2 75–100 mmHg and PaCO2 35–45 mmHg).
Design and setting
Prospectively collected data were analysed from five Pediatric Resuscitation Quality collaborative sites supplemented with retrospective PaO2 and PaCO2 data.
Patients
Children aged 1 day–17 years with return of circulation after cardiac arrest, admitted 2019–2022, with ≥ 4 arterial blood gasses spanning at least 12 h within 24 h post-return of ciculation, were eligible. Congenital cyanotic heart disease events were excluded.
Measurements
Area under the curve calculation provided hourly cumulative PaO2 and PaCO2 exposures per child and similarly guideline recommended cumulative ranges. The primary outcome was survival to hospital discharge with favorable neurologic outcome defined as a Pediatric Cerebral Performance Category 1–3, or no pre-arrest baseline difference.
Main results
Among 292 included children (median age 2.6 years (IQR 0.4–10.9)), 57 % survived to discharge and 48 % had favorable neurologic outcome (88 % of survivors). Cumulative PaO2 and PaCO2 exposure 0–24 h post-return of circulation were not significantly associated with favorable neurologic outcome in multivariable analysis (OR 1.0, 95 %CI 0.98–1.02 and OR 0.97, 95 %CI 0.87–1.09 respectively). Cumulative PaO2 and PaCO2 remained within guideline recommended ranges for 24 % and 58 % of children respectively with median areas under the curve over 0 – 24 h of 2664 mmHg (2151 – 3249 mmHg) for PaO2 and 948 mmHg (853 – 1051 mmHg) for PaCO2. AHA post-cardiac arrest care guideline recommendations for PaO2 (1800–2400 mmHg) and PaCO2 (840–1080 mmHg) were recalculated as area under the curve ranges. Achieving both normoxia and normocapnia was observed in 12 % of children.
Conclusions
Cumulative PaO2 and PaCO2 exposure in the first 24 h post-return of circulation was not associated with survival with favorable neurologic outcome. Pediatric AHA post-cardiac arrest care guideline normoxia and normocapnia goals were often not met. Larger cohort studies are necessary to improve the accuracy of cumulative exposure calculations, assess the long-term effects of PaO2 and PaCO2 exposure, and explore the influence of other post-cardiac arrest care therapeutic strategies.